On the heels of recent final guidance from FDA on ctDNA in clinical trials, I noticed a pair of splash-ads from Labcorp promoting biopharma use of its comprehensive genomic profiling CGP, Labcorp Tissue Complete, and its ctDNA test, Labcorp Plasma detect:
Tissue Complete "powereed by PGDx elio," leads to a four-page PDF:
The ctDNA splash ad leads to a three-page PDF:
https://content.labcorp.com/sites/default/files/2024-09/Plasma%20Detect%20Infosheet_409950_0824.pdf
Labcorp seems to emphasize it spans 'end to end" services, it's not just a CDx kit manufacturer that produces a box. The CGP service notes, for example, "While CGP holds immense potential to enhance the precision and effectiveness of oncology therapeutics, biopharmaceutical companies can benefit from Labcorp’s global capabilities across the entire product development life cycle. As an end-to-end partner from preclinical discovery through commercialization, we offer the insights and capabilities to help you bring the power of precision medicine to the patients who need it."
